A pdf file with the requested content has been emailed to you.
I understand. Hide this message.
I understand. Hide this message.
Randomized, comparative study of interferon beta-1a treatment regimens in MS
The physician payment reporting provisions of the Patient Protection and Affordable Care Act of 2010 (the "Sunshine Provisions") require that all applicable manufacturers, including EMD Serono, Inc., track and report to Centers for Medicare & Medicaid Services (CMS) all transfers of value to U.S. physicians, specifically including the value of journal reprints.
